(Q36709995)

15 August 2017

1 reference

title

Immunopathogenesis of poxvirus infections: forecasting the impending storm (English)

1 reference

Poxviridae infectious disease

15 August 2017

main subject

1 reference

2

Grant McFadden

1 reference

15 August 2017

Marianne M Stanford

1

1 reference

15 August 2017

Gunasegaran Karupiah

series ordinal

3

1 reference

15 August 2017

Geeta Chaudhri

series ordinal

4

1 reference

15 August 2017

publication date

16 January 2007

1 reference

Immunology & Cell Biology

15 August 2017

published in

1 reference

15 August 2017

volume

85

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

93-102

1 reference

Molluscum contagiosum: its clinical, histopathologic, and immunohistochemical spectrum

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Immunology 101 at poxvirus U: immune evasion genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Poxvirus orthologous clusters: toward defining the minimum essential poxvirus genome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Poxviruses: past, present and future.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Poxviruses and immune evasion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

1 reference

7 January 2021

Countermeasures to the bioterrorist threat of smallpox

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Transmission potential of smallpox: estimates based on detailed data from an outbreak

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

The biological characters of several strains of vaccinia, cowpox and rabbitpox viruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Immune response to poxvirus infections in various animals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Ectromelia virus: the causative agent of mousepox

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Viral mimicry of cytokines, chemokines and their receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Poxvirus immunomodulatory strategies: current perspectives

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Technical knockout: understanding poxvirus pathogenesis by selectively deleting viral immunomodulatory genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Immunomodulation by viruses: the myxoma virus story

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Immune responses to myxoma virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Poxvirus immune modulators: functional insights from animal models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

A pox on thee! Manipulation of the host immune system by myxoma virus and implications for viral-host co-adaptation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

The pathogenesis of the acute exanthems; an interpretation based on experimental investigations with mousepox; infectious ectromelia of mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

The virology of variola minor. Correlation of laboratory tests with the geographic distribution and human virulence of variola isolates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Genome sequence diversity and clues to the evolution of variola (smallpox) virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

The pathogenicity of variola virus: A comparison of the growth of standard strains of variola major and variola minor viruses in cell cultures from human embryos

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Alastrim smallpox variola minor virus genome DNA sequences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Type 1 and type 2 cytokines in antiviral defense.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

The 'supervirus'? Lessons from IL-4-expressing poxviruses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Haemorrhagic smallpox

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Virus and virus antigen in the blood of smallpox patients; their significance in early diagnosis and prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Smallpox: Clinical Types, Causes of Death, and Treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Vaccinia virus immune evasion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

A review of compounds exhibiting anti-orthopoxvirus activity in animal models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Cidofovir in the treatment of poxvirus infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Immunomodulatory proteins of myxoma virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Lessons in Détente or know thy host: The immunomodulatory gene products of myxoma virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Obligatory requirement for antibody in recovery from a primary poxvirus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Serial backcross analysis of genetic resistance to mousepox, using marker loci for Rmp-2 and Rmp-3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Cell-mediated cytotoxicity in recovery from poxvirus infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

A role for early cytotoxic T cells in resistance to ectromelia virus infection in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Interferon function is not required for recovery from a secondary poxvirus infection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Cytokines and immunity to viral infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

A comparison of the virulence for European rabbits (Oryctolagus cuniculus) of strains of myxoma virus recovered in the field in Australia, Europe and America

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Myxoma virus in rabbits.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Virulence and pathogenesis of the MSW and MSD strains of Californian myxoma virus in European rabbits with genetic resistance to myxomatosis compared to rabbits with no genetic resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Interruption of cytokine networks by poxviruses: lessons from myxoma virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Coevolution of host and virus: cellular localization of virus in myxoma virus infection of resistant and susceptible European rabbits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

The Complete DNA Sequence of Myxoma Virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Sequence mapping of the Californian MSW strain of Myxoma virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

The detection of monkeypox in humans in the Western Hemisphere.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Human monkeypox: clinical features of 282 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Reemergence of monkeypox: prevalence, diagnostics, and countermeasures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

A tale of two clades: monkeypox viruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Virulence differences between monkeypox virus isolates from West Africa and the Congo basin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Anti-immunology: evasion of the host immune system by bacterial and viral pathogens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Smallpox antiviral drug development: satisfying the animal efficacy rule

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Pox viral vaccine approaches.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

1 reference

7 January 2021

Fighting cancer with vaccinia virus: teaching new tricks to an old dog.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

The use of oncolytic vaccinia viruses in the treatment of cancer: a new role for an old ally?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Prevention of chronic renal allograft rejection by SERP-1 protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Secreted immunomodulatory viral proteins as novel biotherapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Transplant vasculopathy: viral anti-inflammatory serpin regulation of atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Detection of transplant vasculopathy in a rat aortic allograft model by fluorescence spectroscopic optical analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Virus-encoded serine proteinase inhibitor SERP-1 inhibits atherosclerotic plaque development after balloon angioplasty

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Pathogen-derived immunomodulatory molecules: future immunotherapeutics?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100033

7 January 2021

Identifiers

DOI

10.1038/SJ.ICB.7100033

1 reference

15 August 2017

1 reference